Neurophyxia is an innovative clinical drug development company developing novel drugs to reduce the deleterious effects of oxygen shortage in the brain. Our lead product 2-IB  is currently in Phase II Clinical Trials for 3 indications:

• Stroke in adults
• Cardiac Arrest in adults
• Birth Asphyxia in newborns.